Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Kritikos

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Lupus|March 1, 2005
Lupus nephritis flaresP I Sidiropoulos, H D Kritikos, D T Boumpas
Current Rheumatology Reports|December 21, 2000
Perspective on future therapy of vasculitisD T Boumpas, H D Kritikos, N G Daskalakis
Lupus|February 25, 2010
Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosusA Raptopoulou, C Linardakis, P Sidiropoulos, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomideE K Spanakis, G A Katsikas, P I Sidiropoulos, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefitP Sidiropoulos, G Bertsias, H D Kritikos, et al.
Clinical and Experimental Rheumatology|August 13, 2005
Low dose of infliximab is inadequate in most patients with spondylarthropathiesP Sidiropoulos, H D Kritikos, P Siakka, et al.
Clinical and Experimental Rheumatology|April 10, 2007
Infliximab therapy in pulmonary fibrosis associated with collagen vascular diseaseK M Antoniou, M Mamoulaki, K Malagari, et al.
Clinical and Experimental Rheumatology|July 17, 2007
Chronic alcohol consumption as a predisposing factor for multiple tendon ruptures in unusual sites in a patient with rheumatoid arthritisL A Bourikas, H D Kritikos, O G Papakostantinou, et al.
Clinical and Experimental Rheumatology|December 3, 2010
An underlying systemic disease is common among patients with chronic, treatment resistant urticaria, referred to a tertiary referral centre for autoimmune diseasesG Katsikas, Z T Karageorgaki, G K Bertsias, et al.
Leukemia & Lymphoma|April 12, 2003
Non-Hodgkin's lymphoma in patients with systemic lupus erythematosusH A Papadaki, I Xylouri, G Katrinakis, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Lupus|March 1, 2005
Lupus nephritis flaresP I Sidiropoulos, H D Kritikos, D T Boumpas
Current Rheumatology Reports|December 21, 2000
Perspective on future therapy of vasculitisD T Boumpas, H D Kritikos, N G Daskalakis
Lupus|February 25, 2010
Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosusA Raptopoulou, C Linardakis, P Sidiropoulos, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomideE K Spanakis, G A Katsikas, P I Sidiropoulos, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefitP Sidiropoulos, G Bertsias, H D Kritikos, et al.
Clinical and Experimental Rheumatology|August 13, 2005
Low dose of infliximab is inadequate in most patients with spondylarthropathiesP Sidiropoulos, H D Kritikos, P Siakka, et al.
Clinical and Experimental Rheumatology|April 10, 2007
Infliximab therapy in pulmonary fibrosis associated with collagen vascular diseaseK M Antoniou, M Mamoulaki, K Malagari, et al.
Clinical and Experimental Rheumatology|July 17, 2007
Chronic alcohol consumption as a predisposing factor for multiple tendon ruptures in unusual sites in a patient with rheumatoid arthritisL A Bourikas, H D Kritikos, O G Papakostantinou, et al.
Clinical and Experimental Rheumatology|December 3, 2010
An underlying systemic disease is common among patients with chronic, treatment resistant urticaria, referred to a tertiary referral centre for autoimmune diseasesG Katsikas, Z T Karageorgaki, G K Bertsias, et al.
Leukemia & Lymphoma|April 12, 2003
Non-Hodgkin's lymphoma in patients with systemic lupus erythematosusH A Papadaki, I Xylouri, G Katrinakis, et al.
Pageof 2